Preventive effect of Diallyl Trisulfide on cutaneous toxicities induced by EGFR inhibitor
Sign Up to like & getrecommendations! Published in 2019 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2019.01.023
Abstract: &NA; Cutaneous toxicities are the commonest side effects in patients with cancer treated using epidermal growth factor receptor inhibitors such as erlotinib. For patients with such toxicities, there is a lack of safe, effective pharmacological… read more here.
Keywords: diallyl trisulfide; group; skin; effect diallyl ... See more keywords